FDA Inspection
Lupin LimitedLupin Limited – FDA Inspection, Aug 31, 2018
Record Details
This FDA Inspection record concerns Lupin Limited, with an inspection on August 31, 2018, issued by the Office of Inspections and Investigations, covering human drugs.
- People
- Andrew J. Idzior (FDA Associated Person)
- Carrie A. Hughes (Issuing Officer)
- Eric L. Dong (Issuing Officer)
View Company Profile
ID · c0c911eb-d78b-4bd7-ae32-212047023ee8
Inspection Facts
- Inspection number
- 1065374
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Lupin Limited
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 4, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 21, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 7, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lupin Limited
- FDA Inspection 1166309 - 2022-04-04
- FDA Inspection 1107143 - 2019-09-20
- FDA Inspection 940837 - 2015-08-21
- FDA Inspection 799360 - 2012-06-07
- FDA Inspection 568102 - 2009-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.